5.2(top 5%)
impact factor
5.1K(top 5%)
papers
161.4K(top 5%)
citations
134(top 5%)
h-index
5.4(top 5%)
impact factor
6.2K
all documents
171.9K
doc citations
217(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance testLiver International20047,546
2The global burden of hepatitis CLiver International20091,150
3Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE StudyLiver International2015813
4Diagnosis and phenotypic classification of Wilson disease1Liver International2003726
5Role of Kupffer cells in host defense and liver diseaseLiver International2006707
6Liver injury during highly pathogenic human coronavirus infectionsLiver International2020680
7The epidemiology of non‐alcoholic fatty liver diseaseLiver International2017503
8A systematic review of hepatitis C virus epidemiology in Asia, Australia and EgyptLiver International2011481
9Non‐invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis BLiver International2009432
10Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitusLiver International2009427
11Cholangiocarcinoma: Epidemiology and risk factorsLiver International2019420
12Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunityLiver International2012396
13Liver impairment in COVID‐19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, ChinaLiver International2020388
14Meta‐analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosisLiver International2013370
15Comparison of MAFLD and NAFLD diagnostic criteria in real worldLiver International2020362
16Liver diseases: A major, neglected global public health problem requiring urgent actions and large‐scale screeningLiver International2018361
17Hepatitis C virus infection in USA: an estimate of true prevalenceLiver International2011355
18Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatmentLiver International2008350
19Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitisLiver International2011337
20Hepatitis E and pregnancy: understanding the pathogenesisLiver International2008336
21A systematic review of hepatitis C virus epidemiology in Europe, Canada and IsraelLiver International2011333
22Biology and significance of alpha‐fetoprotein in hepatocellular carcinomaLiver International2019327
23Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 updateLiver International2005313
24The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patientsLiver International2010313
25Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastographyLiver International2012303
26Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the futureLiver International2018297
27Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studiesLiver International2009294
28Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosisLiver International2012284
29Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastographyLiver International2012283
30MAFLD identifies patients with significant hepatic fibrosis better than NAFLDLiver International2020274
31Pathophysiological mechanisms of liver injury in COVID‐19Liver International2021273
32Safety and efficacy of sofosbuvir‐containing regimens in hepatitis C‐infected patients with impaired renal functionLiver International2016270
33Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long‐term results of a randomized multicentre studyLiver International2007264
34Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver diseaseLiver International2010258
35Experimental models of hepatic encephalopathy: ISHEN guidelinesLiver International2009254
36Bilirubin in clinical practice: a reviewLiver International2008252
37Clinical characteristics of non‐ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective studyLiver International2020252
38COVID‐19 and liver diseaseLiver International2020252
39Pathology of non‐alcoholic fatty liver diseaseLiver International2017247
40Predictive value of ALT levels for non‐alcoholic steatohepatitis (NASH) and advanced fibrosis in non‐alcoholic fatty liver disease (NAFLD)Liver International2013245
41Therapeutic strategies against TGF-β signaling pathway in hepatic fibrosisLiver International2006238
42Nutritional status: its influence on the outcome of patients undergoing liver transplantationLiver International2010233
43Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesisLiver International2003231
44Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseasesLiver International2008231
45The pan‐caspase inhibitor Emricasan (IDN‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitisLiver International2015231
46Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measuresLiver International2006230
47Angiogenesis in chronic liver disease and its complicationsLiver International2011226
48Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patientsLiver International2010225
49Consensus on extra-hepatic portal vein obstructionLiver International2006224
50Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterationsLiver International2020220